UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000024551 |
|---|---|
| Receipt number | R000028254 |
| Scientific Title | PhaseII study of the efficacy of DOCETAXEL plus RAMUCIRUMAB for NSCLC with brain metastasis |
| Date of disclosure of the study information | 2016/11/19 |
| Last modified on | 2020/10/27 20:29:36 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/10/24 21:20:40 | ||
| 2 | Update | 2016/12/13 10:26:29 | UMIN ID1 |
|
| 3 | Update | 2017/04/25 18:30:46 | Public title Public title Acronym Acronym |
|
| 4 | Update | 2017/04/25 18:35:57 | Narrative objectives1 Narrative objectives1 Key secondary outcomes |
|
| 5 | Update | 2017/04/25 19:07:07 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 6 | Update | 2017/04/25 19:08:38 | Anticipated trial start date |
|
| 7 | Update | 2018/04/19 11:43:39 | Recruitment status |
|
| 8 | Update | 2020/10/27 20:23:55 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Research ethics review Post marketing survey by drug manufacture etc., specified by Japanese law. Organization Organization Address Address Tel |
|
| 9 | Update | 2020/10/27 20:27:45 | Recruitment status Date of IRB Last follow-up date |
|
| 10 | Update | 2020/10/27 20:29:36 | Number of participants that the trial has enrolled |
